Fabio Liberante

Wellcome Trust Sanger Institute

I am currently a Postdoctoral Fellow at the Wellcome Trust Sanger Institute, Cambridge, UK as part of their new Synthetic Genomics Group.

Previously, I was based at the Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria. Working in the lab of Prof. Florian Grebien, I studied the interactome of leukaemia-associated fusion oncogenes through mass spectrometry and CRISPR/Cas9. I completed my undergraduate degree in Genetics at Queen’s University Belfast in Northern Ireland. After a short, but incredibly useful, spell in industry I began a PhD at the Centre for Cancer Research and Cell Biology in Belfast. In the lab of Prof. Ken Mills, I worked on understanding the transcriptional changes involved in myelodysplastic syndrome development and progression to leukaemia. My first Postdoc there developed and investigated genetic models of SF3B1 gene mutation using CRISPR/Cas9.

Whether applicable to my own research in understanding human disease or to basic biology, my passion lies in learning about new additions to the increasingly powerful molecular toolbox.

Sign up to customise the site to your preferences and to receive alerts

Register here